Mykacet en es it fr

Mykacet Brand names, Mykacet Analogs

Mykacet Brand Names Mixture

  • No information avaliable

Mykacet Chemical_Formula


Mykacet RX_link

Mykacet fda sheet

Mykacet FDA

Mykacet msds (material safety sheet)

Mykacet MSDS

Mykacet Synthesis Reference

No information avaliable

Mykacet Molecular Weight

926.09 g/mol

Mykacet Melting Point


Mykacet H2O Solubility

360 mg/L

Mykacet State


Mykacet LogP


Mykacet Dosage Forms

Cream; Drops; Liquid; Ointment; Suspension; Tablet

Mykacet Indication

For treatment of cutaneous or mucocutaneous mycotic infections caused by Candida species

Mykacet Pharmacology

Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

Mykacet Absorption

Nystatin is not absorbed from intact skin or mucous membrane

Mykacet side effects and Toxicity

No information avaliable

Mykacet Patient Information

No information avaliable

Mykacet Organisms Affected